Integer Holdings Corp

Integer Holdings Corporation announced it will host a conference call to discuss its second quarter financial results and business highlights for the period ended July 3, 2026. The webcast and call are scheduled for Thursday, August 6, 2026, at 8 a.m. CT (9 a.m. ET). The company will release its financial results for the second quarter prior to the conference call on the same day.

Integer Holdings Corporation announced that Jim Stephens, President of Cardiac Rhythm Management & Neuromodulation, will transition to Executive Vice President, Special Projects, effective June 29, 2026. His new role is set to conclude on March 31, 2027. In connection with this change, Mr. Stephens will not be eligible for short-term or long-term incentive awards in 2027. His separation on the termination date will be considered a termination without Cause if a Change of Control occurs before then and he remains employed.

Integer Holdings Corporation, a leading medical device contract development and manufacturing organization, announced its participation in the Truist Securities 2026 MedTech Conference. Members of Integer's executive leadership team will engage in a fireside chat on June 16, 2026, at 10:40 a.m. ET. A live webcast and replay of the event will be accessible via the investor relations section of the company's website.

Integer Holdings Corporation's stockholders approved the 2026 Omnibus Incentive Plan, which replaces the 2021 Plan and reserves a maximum of 1,000,000 new shares for issuance, alongside shares from the prior plan. Additionally, the Board and Compensation Committee approved cash retention bonuses for key executives, including $1,750,000 for CEO Payman Khales, with 50% vesting by December 31, 2026, and the remainder upon a change in control. Amendments to employment agreements were also approved, providing for accelerated vesting of performance-based equity awards for executives in certain change-in-control scenarios.

Integer Holdings Corp reported a significant turnaround in its first-quarter 2026 financial results, swinging to a net income of $16.5 million, or $0.48 diluted EPS, from a net loss of $(22.5) million, or $(0.66) diluted EPS, in the prior year. Sales saw a modest increase of 0.5% to $439.6 million. However, gross profit and operating income both declined, and net cash from operating activities decreased. The company also increased its long-term debt and repurchased $50.0 million in common stock.

Integer Holdings Corp's Board of Directors has initiated a strategic review to maximize stockholder value, considering options like a sale, merger, or strategic business combination. This decision follows strong interest received in the company. Concurrently, Integer reported its first quarter 2026 results, with sales increasing 0.5% to $440 million and GAAP diluted EPS from continuing operations rising 173% to $0.48. The company also updated its 2026 outlook, expecting a return to 200 basis points above-market organic sales growth in 2027.

Integer Holdings Corporation (ITGR) announced its participation in the 2026 Bank of America Healthcare Conference, scheduled for May 12-14, 2026. Members of the executive leadership team will host a fireside chat on Tuesday, May 12, at 1:40 p.m. PT. A live webcast and replay of the event will be available on the Investor Relations section of Integer's website.